OXIG
NEUTRALOxford Instruments Announces Holding Change
The technology company has announced a change in shareholding, with Ameriprise Financial, Inc. reducing its stake in the business.
Oxf Instruments
1,938.00GBX
-1.52%
Market Cap
1.09B
Volume
80.25k
47% of avg
P/E Ratio
16.86
EPS (TTM)
114.98
Beta
0.93
Day Range
1,938.00p - 2,055.00p
52 Week Range
1,470.00p1,938.00p2,200.00p
1,938.00p
Upcoming Events
OXIG
BADOxford Instruments Reports Profit Decline Amid Challenging Market Conditions
The scientific instruments maker faced significant headwinds, reporting a 22.9% drop in adjusted operating profit and a 7.9% revenue decline. Despite challenges, it expects a stronger second half.
OXIG
NEUTRALOxford Instruments Appoints New Auditor
The scientific technology company has appointed Deloitte LLP as its new auditor, replacing BDO LLP.
OXIG
NEUTRALOxford Instruments Navigates Turbulent Markets, Expects Stable Full Year
The scientific technology company navigates turbulent markets, expecting stable full year performance despite H1 revenue decline.
OXIG
BADOxford Instruments Faces Headwinds in H1, Expects Stable Full Year
The scientific technology provider faces headwinds in H1, with revenue down 8% and margin pressure, though expects a stronger second half.
OXIG
NEUTRALOxford Instruments Announces Major Shareholder Holding
The technology company has announced a major shareholder has increased its stake in the business.
OXIG
NEUTRALOxford Instruments Announces Holding Change
The scientific instruments company discloses a change in shareholding, with Aberdeen Group plc now holding over 5% of the voting rights.
OXIG
NEUTRALOxford Instruments Plc Announces Holding(s) in Company
The technology company has announced a change in major shareholding.
OXIG
NEUTRALOxford Instruments Announces Change in Shareholding
The scientific instruments maker has announced a change in its major shareholder structure.
OXIG
NEUTRALOxford Instruments Announces Director/PDMR Shareholding
The scientific instruments company has announced changes to its directors' and PDMRs' shareholdings.